Literature DB >> 9415349

Propofol for sedation in the intensive care unit: essentials for the clinician.

M A Marinella1.   

Abstract

Propofol is a short-acting intravenous anesthetic commonly utilised in the intensive care unit (ICU) for sedation of mechanically ventilated patients. The rapid onset and termination of action make it an attractive drug for use in the ICU. The safety profile of propofol is well established. However, there are potential adverse reactions associated with the drug. This review discusses the pharmacology, administration and adverse effects associated with propofol with which clinicians who administer propofol should be familiar.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415349     DOI: 10.1016/s0954-6111(97)90082-2

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

Review 1.  Acute pancreatitis after single-dose exposure to propofol: a case report and review of literature.

Authors:  Qaiser Jawaid; Michael E Presti; Brent A Neuschwander-Tetri; Frank R Burton
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 2.  Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.

Authors:  D M Steinbacher
Journal:  Anesth Prog       Date:  2001

Review 3.  Propofol: a review of its use in intensive care sedation of adults.

Authors:  Kate McKeage; Caroline M Perry
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 4.  Clinically important drug interactions with intravenous anaesthetics in older patients.

Authors:  Helge Eilers; Claus Niemann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.